Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes.
Russo V, Pilla L, Lunghi F, Crocchiolo R, Greco R, Ciceri F, Maggioni D, Fontana R, Mukenge S, Rivoltini L, Rigamonti G, Mercuri SR, Nicoletti R, Maschio AD, Gianolli L, Fazio F, Marchianò A, Florio AD, Maio M, Salomoni M, Gallo-Stampino C, Fiacco MD, Lambiase A, Coulie PG, Patuzzo R, Parmiani G, Traversari C, Bordignon C, Santinami M, Bregni M. Russo V, et al. Among authors: bordignon c. Int J Cancer. 2013 Jun 1;132(11):2557-66. doi: 10.1002/ijc.27939. Epub 2012 Dec 13. Int J Cancer. 2013. PMID: 23151995
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients.
Fontana R, Bregni M, Cipponi A, Raccosta L, Rainelli C, Maggioni D, Lunghi F, Ciceri F, Mukenge S, Doglioni C, Colau D, Coulie PG, Bordignon C, Traversari C, Russo V. Fontana R, et al. Among authors: bordignon c. Blood. 2009 Feb 19;113(8):1651-60. doi: 10.1182/blood-2008-07-168666. Epub 2008 Dec 12. Blood. 2009. PMID: 19074732 Free article. Clinical Trial.
A dual role for genetically modified lymphocytes in cancer immunotherapy.
Russo V, Bondanza A, Ciceri F, Bregni M, Bordignon C, Traversari C, Bonini C. Russo V, et al. Among authors: bordignon c. Trends Mol Med. 2012 Apr;18(4):193-200. doi: 10.1016/j.molmed.2011.12.003. Epub 2012 Jan 7. Trends Mol Med. 2012. PMID: 22230382 Review.
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.
Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M, Pescarollo A, Bondanza A, Peccatori J, Rossini S, Magnani Z, Salomoni M, Benati C, Ponzoni M, Callegaro L, Corradini P, Bregni M, Traversari C, Bordignon C. Ciceri F, et al. Among authors: bordignon c. Blood. 2007 Jun 1;109(11):4698-707. doi: 10.1182/blood-2006-05-023416. Epub 2007 Feb 27. Blood. 2007. PMID: 17327416 Free article.
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.
Traversari C, Marktel S, Magnani Z, Mangia P, Russo V, Ciceri F, Bonini C, Bordignon C. Traversari C, et al. Among authors: bordignon c. Blood. 2007 Jun 1;109(11):4708-15. doi: 10.1182/blood-2006-04-015230. Epub 2007 Feb 27. Blood. 2007. PMID: 17327417 Free article. Clinical Trial.
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.
Oliveira G, Ruggiero E, Stanghellini MT, Cieri N, D'Agostino M, Fronza R, Lulay C, Dionisio F, Mastaglio S, Greco R, Peccatori J, Aiuti A, Ambrosi A, Biasco L, Bondanza A, Lambiase A, Traversari C, Vago L, von Kalle C, Schmidt M, Bordignon C, Ciceri F, Bonini C. Oliveira G, et al. Among authors: bordignon c. Sci Transl Med. 2015 Dec 9;7(317):317ra198. doi: 10.1126/scitranslmed.aac8265. Sci Transl Med. 2015. PMID: 26659572 Clinical Trial.
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.
Lanterna C, Musumeci A, Raccosta L, Corna G, Moresco M, Maggioni D, Fontana R, Doglioni C, Bordignon C, Traversari C, Russo V. Lanterna C, et al. Among authors: bordignon c. Cancer Immunol Immunother. 2016 Nov;65(11):1303-1315. doi: 10.1007/s00262-016-1884-8. Epub 2016 Aug 12. Cancer Immunol Immunother. 2016. PMID: 27520505 Free PMC article.
204 results